{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:50:32Z","timestamp":1773323432004,"version":"3.50.1"},"reference-count":67,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3892\/mco.2014.460","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T09:51:57Z","timestamp":1416477117000},"page":"267-273","source":"Crossref","is-referenced-by-count":8,"title":["Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer"],"prefix":"10.3892","volume":"3","author":[{"given":"MASATAKA","family":"ADACHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOUJI","family":"BANNO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEGUMI","family":"YANOKURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MIHO","family":"IIDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KANAKO","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUYA","family":"NOGAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KIYOKO","family":"UMENE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENTA","family":"MASUDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IORI","family":"KISU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ARISA","family":"UEKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIRA","family":"HIRASAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EIICHIRO","family":"TOMINAGA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAISUKE","family":"AOKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,20]]},"reference":[{"key":"key20180107145337_b1-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","article-title":"BRCA 1, BRCA 2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing","volume":"178","author":"Rubin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107145337_b2-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"key20180107145337_b3-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA"},{"key":"key20180107145337_b4-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pgp.0000101083.35393.cd","article-title":"Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry","volume":"23","author":"Werness","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"key20180107145337_b5-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"key20180107145337_b6-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1155\/2004\/305058","article-title":"Mutations associated with HNPCC predisposition - Update of ICG-HNPCC\/INSiGHT mutation database","volume":"20","author":"Peltomaki","year":"2004","journal-title":"Dis Markers"},{"key":"key20180107145337_b7-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/138920209787847069","article-title":"Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review)","volume":"10","author":"Banno","year":"2009","journal-title":"Curr Genomics"},{"key":"key20180107145337_b8-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1572-0241.2005.00308.x","article-title":"A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma","volume":"101","author":"Hirata","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key20180107145337_b9-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3892\/ijo.2012.1528","article-title":"Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome (Review)","volume":"41","author":"Banno","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107145337_b10-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107145337_b11-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","article-title":"Cancer risk associated with germline DNA mismatch repair gene mutations","volume":"6","author":"Dunlop","year":"1997","journal-title":"Hum Mol Genet"},{"key":"key20180107145337_b12-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"key":"key20180107145337_b13-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"key20180107145337_b14-mco-03-02-0267","article-title":"Genetic\/familial high-risk assesment: breast and ovarian","author":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology","year":"2014"},{"key":"key20180107145337_b15-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"key20180107145337_b16-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"key20180107145337_b17-mco-03-02-0267","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20180107145337_b18-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/jnci\/dji281","article-title":"Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families","volume":"97","author":"Kauff","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key20180107145337_b19-mco-03-02-0267","article-title":"Colorectal cancer screening","author":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology","year":"2014"},{"key":"key20180107145337_b20-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107145337_b21-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/107327480901600103","article-title":"Endometrial cancer and Lynch syndrome: clinical and pathologic considerations","volume":"16","author":"Meyer","year":"2009","journal-title":"Cancer Control"},{"key":"key20180107145337_b22-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJMe058284","article-title":"Reducing the risk of gynecologic cancer in the Lynch syndrome","volume":"354","author":"Offit","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107145337_b23-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.seminoncol.2007.07.004","article-title":"Screening and prevention of hereditary gynecologic cancers","volume":"34","author":"Kehoe","year":"2007","journal-title":"Semin Oncol"},{"key":"key20180107145337_b24-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jjco\/hyt036","article-title":"Experience of risk-reducing salpingo-oophorectomy for BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: Our challenges for the future","volume":"43","author":"Hirasawa","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107145337_b25-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.maturitas.2010.03.018","article-title":"Short-term surgical outcome and safety of risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers","volume":"66","author":"Kenkhuis","year":"2010","journal-title":"Maturitas"},{"key":"key20180107145337_b26-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2010.05.026","article-title":"Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: surgical outcomes and learning curve analysis","volume":"119","author":"Escobar","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107145337_b27-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key20180107145337_b28-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"key20180107145337_b29-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in Jewish women with uterine serous papillary carcinoma","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key20180107145337_b30-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.08.004","article-title":"The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study","volume":"104","author":"Beiner","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180107145337_b31-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2006.01.006","article-title":"Role of prophylactic hysterectomy in patients at high risk for hereditary cancers","volume":"102","author":"Villella","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key20180107145337_b32-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10689-005-1838-3","article-title":"Gynecologic cancers in Lynch syndrome\/HNPCC","volume":"4","author":"Lu","year":"2005","journal-title":"Fam Cancer"},{"key":"key20180107145337_b33-mco-03-02-0267","first-page":"CD003677","article-title":"Surgical approach to hysterectomy for benign gynaecological disease","volume":"(3)","author":"Nieboer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key20180107145337_b34-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u2018sentinel cancer\u2019 for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"key20180107145337_b35-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"key20180107145337_b36-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"key20180107145337_b37-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000267500.27329.85","article-title":"Gynecologic cancer prevention in Lynch syndrome\/hereditary nonpolyposis colorectal cancer families","volume":"110","author":"Chen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key20180107145337_b38-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2011.04.004","article-title":"Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1\/2 mutation carriers","volume":"122","author":"Chapman","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107145337_b39-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"key20180107145337_b40-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review","volume":"296","author":"Lindor","year":"2006","journal-title":"JAMA"},{"key":"key20180107145337_b41-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/AOG.0b013e3181b6f4f9","article-title":"Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome","volume":"115","author":"Schmeler","year":"2010","journal-title":"Obstet Gynecol"},{"key":"key20180107145337_b42-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"key20180107145337_b43-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20180107145337_b44-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"key20180107145337_b45-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study","volume":"24","author":"Barakat","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107145337_b46-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"key20180107145337_b47-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0140-6736(91)90417-N","article-title":"Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer","volume":"338","author":"Voigt","year":"1991","journal-title":"Lancet"},{"key":"key20180107145337_b48-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"key":"key20180107145337_b49-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/09513590.2010.488778","article-title":"Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis","volume":"27","author":"Eden","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key20180107145337_b50-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107145337_b51-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"key20180107145337_b52-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1200\/JCO.2011.39.5590","article-title":"Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study","volume":"30","author":"Win","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107145337_b53-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11912-012-0273-5","article-title":"Preventive therapy for breast cancer","volume":"14","author":"Sestak","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"key20180107145337_b54-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertil Steril"},{"key":"key20180107145337_b55-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"key20180107145337_b56-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cncr.23956","article-title":"Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin","volume":"115","author":"Pearce","year":"2009","journal-title":"Cancer"},{"key":"key20180107145337_b57-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/jnci\/djj375","article-title":"Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort","volume":"98","author":"Lacey","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key20180107145337_b58-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/ijc.25515","article-title":"Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen","volume":"127","author":"Hildebrand","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107145337_b59-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/1078-0432.CCR-09-2953","article-title":"New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy","volume":"16","author":"Miller","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107145337_b60-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10434-000-0325-1","article-title":"Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery","volume":"7","author":"Kuerer","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"key20180107145337_b61-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-144-6-200603210-00006","article-title":"Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2mutation","volume":"144","author":"Anderson","year":"2006","journal-title":"Ann Intern Med"},{"key":"key20180107145337_b62-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ygyno.2012.08.031","article-title":"Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome","volume":"127","author":"Yurgelun","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180107145337_b63-mco-03-02-0267","first-page":"9","article-title":"Prophylactic salpingo-oophorectomy in a woman with high-risk for ovarian carcinoma: A case report","volume":"42","author":"Ichikawa","year":"2005","journal-title":"Kanto J Obstet Gynecol"},{"key":"key20180107145337_b64-mco-03-02-0267","first-page":"A27","article-title":"Risk-reducing surgery for patients with hereditary breast and ovarian cancer","volume":"12","author":"Arai","year":"2012","journal-title":"Jpn Soc Fam Tumors"},{"key":"key20180107145337_b65-mco-03-02-0267","first-page":"293","article-title":"A case of Lynch syndrome intervened early after genetic testing","volume":"60","author":"Nakamura","year":"2011","journal-title":"Tokyo J Obstet Gynecol"},{"key":"key20180107145337_b66-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s00268-010-0477-5","article-title":"Choice of management of southern Chinese BRCA mutation carriers","volume":"34","author":"Kwong","year":"2010","journal-title":"World J Surg"},{"key":"key20180107145337_b67-mco-03-02-0267","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10689-013-9625-z","article-title":"Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation","volume":"12","author":"Kim","year":"2013","journal-title":"Fam Cancer"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.460\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T14:53:59Z","timestamp":1515336839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,20]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,11,20]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.3892\/mco.2014.460"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.460","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,20]]}}}